Cancer Genetics and Epigenetics 2024, Vol.12, No.2, 88-96 http://medscipublisher.com/index.php/cge 95 Acknowledgments The publisher greatly appreciates the opinions of the two peer reviewers. Conflict of Interest Disclosure The author affirms that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. References Brooks J., Cairns P., and Zeleniuch-Jacquotte A., 2009, Promoter methylation and the detection of breast cancer, Cancer Causes and Control, 20: 1539-1550. https://doi.org/10.1007/s10552-009-9415-y Cheuk I., Shin V., and Kwong A., 2017, Detection of methylated circulating DNA as noninvasive biomarkers for Breast cancer diagnosis, Journal of Breast Cancer, 20: 12-19. https://doi.org/10.4048/jbc.2017.20.1.12 Constâncio V., Nunes S., Henrique R., and Jerónimo C., 2020, DNA methylation-based testing in liquid biopsies as detection and prognostic biomarkers for the four major cancer types, Cells, 9(3): 624. https://doi.org/10.3390/cells9030624 Ennour-Idrissi K., Dragic D., Durocher F., and Diorio C., 2020, Epigenome-wide DNA methylation and risk of breast cancer: a systematic review, BMC Cancer, 20: 1-10. https://doi.org/10.1186/s12885-020-07543-4 Giridhar K., Couch F., Sinnwell J., Slettedahl S., Taylor W., Mahoney D., Foote P., O'Connell M., Robran M., Devens M., Gonser A., Larson N., Doering K., Burger K., Kaiser M., Allawi H., Ruddy K., Olson J., and Kisiel J., 2023, Abstract P2-11-06: plasma assay of methylated DNA markers (MDM) detects patients with metastatic breast cancer (MBC) compared to healthy controls and treated breast cancer patients with no evidence of disease, Cancer Research, 83(5_Supplement): P2-11. https://doi.org/10.1158/1538-7445.SABCS22-P2-11-06 Guan Z., Yu H., Ćuk K., Zhang Y., and Brenner H., 2018, Whole-Blood DNA methylation markers in early detection of breast cancer: a systematic literature review, Cancer Epidemiology Biomarkers and Prevention, 28: 496-505. https://doi.org/10.1158/1055-9965.EPI-18-0378 Hill V., Ricketts C., Bièche I., Vacher S., Gentle D., Lewis C., Maher E., and Latif F., 2011, Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity., Cancer Research, 71(8): 2988-2999. https://doi.org/10.1158/0008-5472.CAN-10-4026 Hoque M., Feng Q., Touré P., Dem A., Critchlow C., Hawes S., Wood T., Jerónimo C., Rosenbaum E., Stern J., Yu M., Trink B., Kiviat N., and Sidransky D., 2006, Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer., Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 24(26): 4262-4269. https://doi.org/10.1200/JCO.2005.01.3516 Korshunova Y., Maloney R., Lakey N., Citek R., Bacher B., Budiman A., Ordway J., McCombie W., Leon J., Jeddeloh J., and McPherson J., 2007, Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA., Genome Research, 18(1): 19-29. https://doi.org/10.1101/gr.6883307 Kristensen L., Mikeska T., Krypuy M., and Dobrovic A., 2008, Sensitive melting analysis after real time- methylation specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection, Nucleic Acids Research, 36: e42. https://doi.org/10.1093/nar/gkn113 Li J., Guan X., Fan Z., Ching L., Li Y., Wang X., Cao W., and Liu D., 2020, Non-Invasive biomarkers for early detection of breast cancer, Cancers, 12(10): 2767. https://doi.org/10.3390/cancers12102767 Li Z., Guo X., Tang L., Peng L., Chen M., Luo X., Wang S., Xiao Z., Deng Z., Dai L., Xia K., and Wang J., 2016, Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing, Tumor Biology, 37: 13111-13119. https://doi.org/10.1007/s13277-016-5190-z Liu J., Zhao H., Huang Y., Xu S., Zhou Y., Zhang W., Li J., Ming Y., Wang X., Zhao S., Li K., Dong X., Ma Y., Qian T., Chen X., Xing Z., Zhang Y., Chen H., Liu Z., Pang D., Zhou M., Wu Z., Wang X., Wang X., Wu N., and Su J., 2021, Genome-wide cell-free DNA methylation analyses improve accuracy of non-invasive diagnostic imaging for early-stage breast cancer, Molecular Cancer, 20: 1-7. https://doi.org/10.1186/s12943-021-01330-w Liu M., Oxnard G., Klein E., Swanton C., Swanton C., Seiden M., Liu M., Oxnard G., Curtis C., and Berry D., 2020, Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA, Annals of Oncology: Official Journal of the European Society for Medical Oncology, 31: 745-759. https://doi.org/10.1016/j.annonc.2020.06.008 Luo H., Wei W., Ye Z., Zheng J., and Xu R., 2021, Liquid biopsy of methylation biomarkers in cell-free DNA, Trends in Molecular Medicine, 27(5): 482-500. https://doi.org/10.1016/j.molmed.2020.12.011 Luo R., Chong W., Zhang Z., Abu-Khalaf M., Silver D., Fellin F., Jaslow R., Lopez A., Cescon T., Ip K., Myers R., Wei Q., Li B., Wang C., and Yang H., 2023, Abstract P5-06-05: whole-genome bisulfite sequencing of single circulating tumor cells identifies cellular methylation heterogeneity in metastatic breast cancer, Cancer Research, 83(5_Supplement): P5-06. https://doi.org/10.1158/1538-7445.SABCS22-P5-06-05
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==